ISIS 2503 is under investigation in clinical trial NCT00004193 (ISIS 2503 in Treating Patients With Metastatic And/or Locally Recurrent Colorectal Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.